According to a recent study, Pradaxa and Xarelto bleeding complications may be no less prevalent than those associated with warfarin, an anticoagulant (blood thinner) that has been on the market for many years. The study contradicts some claims made about the newer drugs in terms of their overall safety and... Read more »

Researchers at Johns Hopkins are suggesting that the use of two popular “new generation” blood thinners may run as much as twice the risk of gastrointestinal bleeding as the drug they are trying to replace. Despite recent research that has established that Pradaxa and Xarelto carry a significant increase in... Read more »

An investigation by Deborah Cohen of the British Medical Journal (BMJ) has revealed that Pradaxa manufacturer Boehringer Ingelheim may have withheld analyses that might have prevented some Pradaxa bleeding events. Monitoring and dosing adjustments could make use of the drug even safer and more effective, according to Cohen’s findings. However, the... Read more »

In a statement issued on May 28, 2014, the pharmaceutical giant Boehringer Ingelheim announced that they had reached a settlement agreement with plaintiffs who filed lawsuits with regard to side effects from Pradaxa, a medication designed and manufactured by the company. The Pradaxa settlement involves a payout of $650 million,... Read more »

With Pradaxa lawsuits on the rise, drug manufacturer Boehringer Ingelheim just suffered another public relations blow with a new report from the healthcare information company AdverseEvents. The company compared adverse events linked to three new anticoagulant drugs on the market today; finding Pradaxa and Xarelto fell far behind Eliquis in... Read more »